Professor Paul Morgan
Projects as PI
- Targeting the terminal pathway in complement-driven disease (01/10/2016 - 30/09/2018)
- Target validation, indication selection/prioritisation, review of pre-clinical validation efforts and overall strategy (08/08/2016 - 18/09/2019)
- Testing activity of mAb CP010 (26/10/2018 - 25/10/2019)
- Testing novel agents in myasthenia gravis models (01/06/2019 - 31/12/2020)
- Testing novel agents in myasthenia gravis models (25/05/2015 - 31/03/2017)
Projects as Co-Investigator
- A tooth for an eye? The role of innate immune activation in glaucoma (01/10/2017 - 31/03/2021)
- Automated 384-capacity real-time quantitative polymerase chain reaction (qPCR) facility (01/08/2012 - 31/07/2013)
- Brain Repair and Intracranial Neurotherapeutics - the Wales BRAIN Unit (01/04/2015 - 31/03/2018)
- CD59 as a Modulator of T Cell Activity In Vivo (01/06/2006 - 30/09/2008)
- Collaborative and redundant roles of CLRs in anti-fungal immunity (01/04/2013 - 31/03/2019)